• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Endocr Pract . Rise in Pediatric New Onset Diabetes and Diabetic Ketoacidosis During the COVID-19 Pandemic

tetano

Editor, Senior Moderator
Endocr Pract


. 2022 Feb 18;S1530-891X(22)00059-3.
doi: 10.1016/j.eprac.2022.02.005. Online ahead of print.
Rise in Pediatric New Onset Diabetes and Diabetic Ketoacidosis During the COVID-19 Pandemic


Melissa A Chambers[SUP] 1 [/SUP], Cherisse Mecham[SUP] 2 [/SUP], Elsa Vazquez Arreola[SUP] 3 [/SUP], Madhumita Sinha[SUP] 3 [/SUP]



Affiliations

Abstract

Objective: Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces a proinflammatory state that causes hyperglycemia and may precipitate diabetic ketoacidosis (DKA) in patients with known or new-onset diabetes. We examined the trends in new-onset diabetes and DKA prior to and following the onset of the COVID-19 pandemic.
Methods: This single center retrospective observational study included pediatric patients (0-<18 years) hospitalized with new-onset type 1 (T1D) or type 2 (T2D) diabetes pre- (March 1, 2018 - February 29[SUP]th[/SUP], 2020) and post-pandemic onset (March 1[SUP]st[/SUP], 2020 - December 31[SUP]st[/SUP], 2020). Demographic, anthropometrics, laboratory and clinical data, and outcomes were obtained.
Results: Among 615 children admitted with new onset diabetes during the entire study period, 401 were admitted pre- and 214 post-pandemic onset. Children admitted with new-onset diabetes in the post-pandemic period were significantly more likely to present with DKA (OR=1.76, 95% CI: 1.24, 2.52) compared to the pre-pandemic phase. Children with DKA post-pandemic, had higher lengths of hospitalization and were significantly more likely to experience severe DKA (OR=2.17, 95% CI: 1.34, 3.52). A higher proportion of children with DKA admitted to the PICU required oxygen support post-pandemic compared to pre-pandemic (8.85% vs 1.92%). Most cases of T2D with DKA occurred following the onset of the pandemic (62.5%) CONCLUSION: A significant rise in T2D cases occurred following the onset of the COVID-19 pandemic with a greater risk for DKA and severe ketoacidosis. Racial disparity was evident with a higher proportion of Black and American Indian children presenting with ketoacidosis following the pandemic onset.

Keywords: COVID-19; Diabetes; children; disparity; ketoacidosis.
 
Back
Top Bottom